Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2016 07:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Participation in Leerink Partners 5th Annual Global Healthcare Conference

SAN DIEGO, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
November 16, 2015 16:13 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Positive Data From Phase 1 Clinical Trial of CD101 IV and Reports Third Quarter 2015 Financial Results

-- Single Ascending Dose Study-Results Demonstrate Excellent Safety and Tolerability and Support Once-Weekly IV Dosing -- -- Management to Host Webcast and Conference Call Tomorrow at 8:00 a.m. ET...
November 10, 2015 07:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at the Jefferies 2015 Global Healthcare Conference in London

SAN DIEGO, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...
August 11, 2015 16:13 ET | Source: Cidara Therapeutics, Inc.

Cidara Reports Second Quarter 2015 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...
August 05, 2015 07:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at the Wedbush PacGrow 2015 Healthcare Conference

SAN DIEGO, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...
June 23, 2015 16:10 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Set to Join Russell Indexes

SAN DIEGO, June 23, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...
May 21, 2015 16:25 ET | Source: Cidara Therapeutics, Inc.

Cidara Reports First Quarter 2015 Financial Results and Provides Corporate Update

SAN DIEGO, May 21, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...
April 15, 2015 07:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Pricing of Initial Public Offering

SAN DIEGO, April 15, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...